There were 509 press releases posted in the last 24 hours and 442,744 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
TG Therapeutics Enters into a Global Collaboration to Develop and Commercialize Novel BET Inhibitors Developed by Jubilant Biosys for the Treatment of Hematological Malignancies

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image